Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
Cash Flow Statement
Cash Flow Statement
Zylox-Tonbridge Medical Technology Co Ltd
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||
| Net Income |
(200)
|
0
|
(114)
|
0
|
(79)
|
0
|
100
|
0
|
|
| Depreciation & Amortization |
13
|
0
|
26
|
0
|
36
|
0
|
38
|
0
|
|
| Stock-Based Compensation |
76
|
0
|
88
|
0
|
86
|
0
|
24
|
0
|
|
| Other Non-Cash Items |
56
|
0
|
(6)
|
0
|
16
|
0
|
2
|
0
|
|
| Cash Interest Paid |
0
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
|
| Change in Working Capital |
14
|
(122)
|
2
|
(60)
|
125
|
221
|
34
|
224
|
|
| Cash from Operating Activities |
(116)
N/A
|
(122)
-5%
|
(91)
+25%
|
(60)
+35%
|
98
N/A
|
221
+124%
|
174
-21%
|
224
+28%
|
|
| Investing Cash Flow | |||||||||
| Capital Expenditures |
(90)
|
(126)
|
(145)
|
(191)
|
(191)
|
(198)
|
(191)
|
(121)
|
|
| Other Items |
(1 239)
|
(1 042)
|
50
|
497
|
(15)
|
(784)
|
(610)
|
(33)
|
|
| Cash from Investing Activities |
(1 328)
N/A
|
(1 168)
+12%
|
(95)
+92%
|
306
N/A
|
(206)
N/A
|
(982)
-376%
|
(801)
+18%
|
(154)
+81%
|
|
| Financing Cash Flow | |||||||||
| Net Issuance of Common Stock |
2 446
|
2 423
|
(25)
|
(2)
|
(54)
|
(64)
|
(67)
|
(109)
|
|
| Net Issuance of Debt |
(34)
|
(5)
|
(5)
|
3
|
44
|
61
|
32
|
(0)
|
|
| Cash Paid for Dividends |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(32)
|
|
| Other |
399
|
(112)
|
(1)
|
0
|
(1)
|
(7)
|
(7)
|
5
|
|
| Cash from Financing Activities |
2 810
N/A
|
2 306
-18%
|
(30)
N/A
|
2
N/A
|
(11)
N/A
|
(11)
+5%
|
(42)
-286%
|
(137)
-226%
|
|
| Change in Cash | |||||||||
| Effect of Foreign Exchange Rates |
(6)
|
(0)
|
4
|
1
|
1
|
(2)
|
1
|
(0)
|
|
| Net Change in Cash |
1 359
N/A
|
1 016
-25%
|
(213)
N/A
|
250
N/A
|
(119)
N/A
|
(774)
-552%
|
(668)
+14%
|
(68)
+90%
|
|
| Free Cash Flow | |||||||||
| Free Cash Flow |
(206)
N/A
|
(247)
-20%
|
(237)
+4%
|
(250)
-6%
|
(92)
+63%
|
23
N/A
|
(17)
N/A
|
102
N/A
|
|